Scale -

  • Ebitda is 96.34 Rs Cr; Annual Growth is 48 %; Continuous Growth over 3 years
  • PBT is 99.65 Rs Cr; Annual Growth is 96 %; Continuous Growth over 3 years; in Top Quartile
  • PAT is 51.11 Rs Cr; Annual Growth is 107 %; Continuous Growth over 3 years
  • Revenue is 333 Rs Cr; Continuous Growth over 3 years
  • Quarterly Profit is 94.7 Rs Cr; Continuous Growth over 3 Quarters; in Top Quartile

Profitability -

  • PBDIT Margin is 28.96 %; Annual Growth is 39 %
  • PAT Margin is 15.36 %; Annual Growth is 93 %; Continuous Growth over 3 years
  • Quarterly Profit margin is 123 %; Continuous Growth over 3 Quarters; in Top Quartile

Return -

  • ROCE is 14.74 %; Annual Growth is 62 %; Continuous Growth over 3 years
  • ROA is 8.2 %; Annual Growth is 95 %; Continuous Growth over 3 years
  • ROE is 15.44 %; Annual Growth is 77 %; Continuous Growth over 3 years; in Top Quartile
  • Asset Turnover is 50 %; Continuous Growth over 3 years

Efficiency -

  • Inventory Turnover Ratio is 4.65; Continuous Growth over 3 years; 5 Year CAGR is 72 %
  • Operating cash flow is 64.14 Rs Cr; 5 Year CAGR is 64 %
  • Current Ratio is 1.37; Continuous Decline over 3 years; in Bottom Quartile
  • Quick Ratio is 0.89; Continuous Decline over 3 years; in Bottom Quartile

Solvancy -

  • Long term Debt is 89.96 Rs Cr; Annual Decline is -33 %; Continuous Decline over 3 years; in Top Quartile
  • Contingent Liabilities is 20.96 Rs Cr; Annual Decline is -82 %; Continuous Decline over 3 years; 5 Year CAGR is -41 %
  • Debt/Equity is 0.52; Continuous Decline over 3 years; in Top Quartile
  • Total Debt is 188 Rs Cr; Continuous Decline over 3 years; in Top Quartile

Quality -

  • Current Tax/PAT is 30 %; Annual Decline is -42 %; Continuous Decline over 3 years
  • Change in Inventories/Total Expenses is -2 %; Annual Decline is -166 %; Continuous Decline over 3 years; in Bottom Quartile
  • Operating cashflow/ebitda is 67 %; 5 Year CAGR is 54 %; Annual Decline is -33 %
  • Operating cashflow/PAT is 125 %; 5 Year CAGR is 54 %; Annual Decline is -52 %; Continuous Decline over 3 years
  • Other Expenses/Total Expenses is 37 %; Continuous Growth over 3 years
  • Exceptional Items/PBT is 4 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Hester Biosciences Approves Capital Contribution in Slyce Agri World LLP for Group Captive Solar Power Generation
Read More
  • Past/current